Quantification of p53 in Epithelial Ovarian Cancer
- 30 September 1997
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 66 (3), 435-438
- https://doi.org/10.1006/gyno.1997.4799
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- p53 overexpression in advanced-stage endometrial adenocarcinomaAmerican Journal of Obstetrics and Gynecology, 1996
- p53 as a Prognostic Indicator in Endometrial CancerGynecologic Oncology, 1996
- The molecular basis of ovarian cancerCancer, 1995
- Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survivalHuman Pathology, 1994
- Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53Cancer, 1994
- Prognostic significance of p53 immunostaining in epithelial ovarian cancer.Journal of Clinical Oncology, 1994
- The p53 tumor suppressor gene frequently is altered in gynecologic cancersAmerican Journal of Obstetrics and Gynecology, 1994
- ImmunohistochemistryPublished by Springer Science and Business Media LLC ,1994
- Spectrum of Mutation and Frequency of Allelic Deletion of the p53 Gene in Ovarian CancerJNCI Journal of the National Cancer Institute, 1993
- p53 Expression in Neoplasms of the Uterine CorpusAmerican Journal of Clinical Pathology, 1992